Practical demonstration of the LumiraDx testing device

Tutorial provided by LumeraDx.

The LumiraDx SARS-CoV-2 Ag Test is designed to be used in health care settings to provide an aid to rapid diagnosis of COVID-19. The test uses a nasal swab specimen from individuals at risk of, or with symptoms of, COVID-19 within the first 12 days of symptom onset.

Welsh Government has purchased 400 LumiraDx Point-of-Care devices with several hundred thousand testing strips to support rapid COVID testing for selected patients with symptoms. The devices provide a rapid test for COVID-19, generating an infection status in approximately 12 minutes (start to finish is 20 minutes).

Mark as Understood


LumeraDx Quick Reference Guide

LumeraDx Test Specifications

LumeraDx Product Insert

LumeraDx Quality Controls

© Institute of Clinical Science and Technology (ICST) 2020